NNVC – NanoViricides Inc

NanoViricides, Inc.

NNVC

$1.38

Name : NanoViricides, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $35,244,428.00

EPSttm : -0.41

NanoViricides, Inc.

$1.38

2.82%

$0.04

NNVC — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

3.26

Margin Of Safety %

Put/Call OI Ratio

0.01

EPS Next Q Diff

0.02

EPS Last/This Y

0.06

EPS This/Next Y

Price

1.4

Target Price

Analyst Recom

Performance Q

2.21

Upside

-483.5%

Beta

1.81

Ticker: NNVC

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	NNVC	1.33	0.01	0.00	7696
2026-10-14	NNVC	1.32	0.01	0.02	7708
2026-10-15	NNVC	1.38	0.01	0.00	7895
2026-10-16	NNVC	1.38	0.01	0.00	8255
2026-10-19	NNVC	1.32	0.01	0.00	7897
2026-10-20	NNVC	1.5	0.01	0.00	7917
2026-10-21	NNVC	1.5	0.01	0.00	8218
2026-10-22	NNVC	1.4	0.01	0.00	8334
2026-10-23	NNVC	1.41	0.01	0.00	8329
2026-10-26	NNVC	1.365	0.01	0.00	8351
2026-10-27	NNVC	1.45	0.01	0.00	8354
2026-10-28	NNVC	1.46	0.01	0.00	8351
2026-10-29	NNVC	1.43	0.01	0.00	8364
2026-10-30	NNVC	1.35	0.01	0.00	8664
2026-11-02	NNVC	1.38	0.01	0.00	8682
2026-11-03	NNVC	1.41	0.01	0.00	8691
2026-11-04	NNVC	1.39	0.01	0.00	8793
2026-11-05	NNVC	1.3	0.01	0.00	8787
2026-11-06	NNVC	1.33	0.01	0.00	8784
2026-11-09	NNVC	1.36	0.01	0.00	8803
2026-11-10	NNVC	1.43	0.01	0.01	8895
2026-11-11	NNVC	1.385	0.01	0.00	9028
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	NNVC	1.32	-	-	-0.35
2026-10-14	NNVC	1.31	-	-	-0.35
2026-10-15	NNVC	1.38	-	-	-0.35
2026-10-16	NNVC	1.37	-	-	-0.35
2026-10-19	NNVC	1.32	-	-	-0.35
2026-10-20	NNVC	1.32	-	-	-0.35
2026-10-21	NNVC	1.51	-	-	-0.35
2026-10-22	NNVC	1.38	-	-	-0.35
2026-10-23	NNVC	1.42	-	-	-0.35
2026-10-26	NNVC	1.36	-	-	-0.35
2026-10-27	NNVC	1.46	-	-	-0.35
2026-10-28	NNVC	1.47	-	-	-0.35
2026-10-29	NNVC	1.45	-	-	-0.35
2026-10-30	NNVC	1.36	-	-	-0.35
2026-11-02	NNVC	1.36	-	-	-0.35
2026-11-03	NNVC	1.40	-	-	-0.35
2026-11-04	NNVC	1.39	-	-	-0.35
2026-11-05	NNVC	1.27	-	-	-0.35
2026-11-06	NNVC	1.33	-	-	-0.35
2026-11-09	NNVC	1.37	-	-	-0.35
2026-11-10	NNVC	1.45	-	-	-0.35
2026-11-11	NNVC	1.40	-	-	-0.35
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	NNVC	0.00	1.98	3.72
2026-10-14	NNVC	0.00	1.98	3.72
2026-10-15	NNVC	0.00	1.98	3.72
2026-10-16	NNVC	0.00	1.98	3.72
2026-10-19	NNVC	0.00	1.98	3.72
2026-10-20	NNVC	0.00	1.98	3.72
2026-10-21	NNVC	0.00	1.98	3.72
2026-10-22	NNVC	0.00	1.98	3.72
2026-10-23	NNVC	0.00	1.98	3.72
2026-10-26	NNVC	0.00	2.04	3.72
2026-10-27	NNVC	0.00	2.04	4.59
2026-10-28	NNVC	0.00	2.04	4.59
2026-10-29	NNVC	0.00	2.04	4.59
2026-10-30	NNVC	0.00	2.04	4.59
2026-11-02	NNVC	0.00	2.11	4.59
2026-11-03	NNVC	0.00	2.11	4.59
2026-11-05	NNVC	0.00	2.11	4.59
2026-11-06	NNVC	0.00	2.11	4.59
2026-11-09	NNVC	0.00	1.64	4.59
2026-11-10	NNVC	0.00	1.64	4.59
2026-11-11	NNVC	0.00	1.64	3.26
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.1

Avg. EPS Est. Current Quarter

-0.09

Avg. EPS Est. Next Quarter

-0.08

Insider Transactions

Institutional Transactions

1.64

Beta

1.81

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-82.5

Target Price

P/E

Forward P/E

PEG

P/S

P/B

3.68

P/Free Cash Flow

EPS

-0.41

Average EPS Est. Cur. Y

-0.35

EPS Next Y. (Est.)

-0.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.39

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ NNVC Healthcare

$1.39

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

10/20

Pullback

17/25

Volume

11/15

Valuation

12/20

TP/AR

2/10

Options

8/10

RSI

51.3

Range 1M

44.8%

Sup Dist

1.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

9/30

Estimates

0/20

Inst/Vol

4/15

Options

6/10

EPS Yr

-7%

EPS NY

52W%

48.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +331.7% upside

Quality

2/30

Valuation

16/30

Growth

5/25

Stability

7/10

LT Trend

2/5

Upside

+331.7%

Quality

NNVC — P/E HistoricalBiotechnology

NanoViricides, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 7

NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections. The company's product portfolio includes NV-387 drug candidate developed for RSV and influenza indications and has completed phase 1a/1b human clinical trial for the evaluation of safety and tolerability; NV-387 as an active ingredient of drug product formulations for the treatment of COVID infections comprising NV-CoV-2 Oral Syrup and NV-CoV-2 Oral Gummies developed for the treatment of COVID infection; The latter, a semi-solid fixed-dose form, which are in phase 1a/1b human clinical trials for enabling body-weight-based dose titration as is required for pediatric treatments. It also offers NV-387 Solution for injection, infusion, and inhalation to treat severe cases that are not hospitalized and carried out by an injection; and injectable solution that delivered directly into the lungs as a fog created using portable battery operated nebulizer devices, which enables action at infection by a respiratory virus, such as coronaviruses, RSV, influenzas, human meta-pneumovirus, certain adenoviruses, and other infections, that can lead to severe pneumonia. In addition, the company develops NV-HHV-1, a skin cream for the treatment of Shingles rash, which has completed non-clinical pharmacology studies; oral drug with NV-HHV-1 as the active ingredient for the treatment of HSV-1 cold sores and HSV-2 genital ulcers; and other drug candidates in HIVCide program for the treatment of Dengue and Ebola virus, as well as provides Nanoviricide platform technology to treat various types of viruses. NanoViricides, Inc. was incorporated in 2005 and is headquartered in Shelton, Connecticut.

NNVC

Latest News

—

Caricamento notizie per NNVC…

stock quote shares NNVC – NanoViricides Inc Stock Price stock today

news today NNVC – NanoViricides Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch NNVC – NanoViricides Inc yahoo finance google finance

stock history NNVC – NanoViricides Inc invest stock market

stock prices NNVC premarket after hours

ticker NNVC fair value insiders trading

NNVC – NanoViricides Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NNVC

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y